Evidence map›Paper›PMID 30744112›Full record

ArticleMetabolites2019

MALDI-TOF-MS Analysis in the Identification of Urine Proteomic Patterns of Gestational Trophoblastic Disease.

Paulina Banach, Paweł Dereziński, Eliza Matuszewska, Jan Matysiak, Hubert Bochyński, Zenon J Kokot, Ewa Nowak-Markwitz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Paulina BanachGynecologic Oncology Department, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland. paula.kog.ump@gmail.com.
Paweł DerezińskiDepartment of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland. p.derezinski@gmail.com.
Eliza MatuszewskaDepartment of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland. eliza.matuszewska@gmail.com.
Jan MatysiakDepartment of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland. jmatysiak@ump.edu.pl.
Hubert BochyńskiGynecologic Oncology Department, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland. h.bochynski@gmail.com.
Zenon J KokotDepartment of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland. zkokot@ump.edu.pl.
Ewa Nowak-MarkwitzGynecologic Oncology Department, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland. ewamarkwitz@poczta.fm.
Poznan University of Medical Sciences · PL

Funding

Narodowe Centrum Nauki 2014/15/B/NZ7/00964
6 · The paper itself

Abstract

Gestational trophoblastic disease (GTD) is a group of highly aggressive, rare tumors. Human chorionic gonadotropin is a common biomarker used in the diagnosis and monitoring of GTD. To improve our knowledge of the pathology of GTD, we performed protein-peptide profiling on the urine of patients affected with gestational trophoblastic neoplasm (GTN). We analyzed urine samples from patients diagnosed with GTN (

Indexed as

biomarkersgestational trophoblastic diseaseMALDI-TOF-MSprotein–peptide profiling

Identifiers

PMID30744112
PMCPMC6409522
OpenAlexW2912224083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.